Multistage sampling for latent variable models

Lifetime Data Analysis

Volumn 13, Issue 4, 2007, Pages 565-581

  Thomas, Duncan C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Biomarkers; Exposure measurement error; Latent variable models; Multistage sampling; Spatial correlation; Study design

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CASE CONTROL STUDY; CHILD; EPIDEMIOLOGY; HUMAN; METHODOLOGY; STATISTICAL MODEL;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; EPIDEMIOLOGIC METHODS; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN;

EID: 37649012282     PISSN: 13807870     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10985-007-9061-1     Document Type: Article

References (38)

1. Albert JH and Chib S (1993). Bayesian-analysis of binary and polychotomous response data. J Am Stat Assoc 88: 669-679
2. Breslow N and Cain K (1988). Logistic regression for two-stage case-control data. Biometrika 75: 11-20
3. Breslow NE and Chatterjee N (1999). Design and analysis of two-phase studies with binary outcome applied to Wilms tumor prognosis. Appl Stat 48: 457-468
4. Breslow NE and Holubkov R (1997). Weighted likelihood, pseudo-likelihood and maximum likelihood methods for logistic regression analysis of two-stage data. Stat Med 16: 103-116
5. Breslow NE and Zhao LP (1988). Logistic regression for stratified case-control studies. Biometrics 44: 891-899
6. Cain K and Breslow N (1988). Logistic regression analysis and efficient design for two-stage studies. Am J Epidemiol 128: 1198-1206
7. Carroll RJ, Ruppert D and Stefanski LA (1995). Measurement error in nonlinear models. Chapman and Hall, London
8. Conti DV, Cortessis V, Molitor J and Thomas DC (2003). Bayesian modeling of complex metabolic pathways. Hum Hered 56: 83-93
9. Cressie NAC (1993). Statistics for spatial data. Wiley & Sons Inc., New York
10. Davey Smith G and Ebrahim S (2004). Mendelian randomization: prospects, potentials and limitations. Int J Epidemiol 33: 30-42
11. Diggle P and Lophaven S (2005). Bayesian geostatistical design. Scand J Stat 33: 53-64
12. Feng Z, Prentice R and Srivastava S (2004). Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective. Pharmacogenomics 5: 709-719
13. Friedman N (2004). Inferring cellular networks using probabilistic graphical models. Science 303: 799-805
14. Gauderman WJ, Avol E, Gilliland F, Vora H, Thomas D, Berhane K, McConnell R, Kuenzli N, Lurmann F, Rappaport E, Margolis H, Bates D and Peters J (2004). The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 351: 1057-1067
15. Gauderman WJ, Avol E, Lurmann F, Kuenzli N, Gilliland F, Peters J and McConnell R (2005). Childhood asthma and exposure to traffic and nitrogen dioxide. Epidemiology 16: 737-743
16. Gauderman WJ, Vora H, McConnell R, Berhane K, Gilliland F, Thomas D, Lurmann F, Avol E, Kunzli N, Jerrett M and Peters J (2007). Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study. Lancet 369: 571-577
17. Greenland S (1988). Statistical uncertainty due to misclassification: implications for validation substudies. J Clin Epidemiol 41: 1167-1174
18. Haile RW, Siegmund KD, Gauderman WJ and Thomas DC (1999). Study-design issues in the development of the University of Southern California Consortium's Colorectal Cancer Family Registry. J Natl Cancer Inst Monogr 26: 89-93
19. Harel O and Zhou XH (2007). Multiple imputation: review of theory, implementation and software. Stat Med 26: 3057-3077
20. Kooperberg C and Ruczinski I (2005). Identifying interacting SNPs using Monte Carlo logic regression. Genet Epidemiol 28: 157-170
21. Kraft P and Thomas DC (2000). Bias and efficiency in family-matched gene-characterization studies: Conditional, prospective, retrospective and joint likelihoods. Am J Hum Genet 66: 1119-1131
22. McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gauderman WJ, Avol E, Margolis HG and Peters JM (2002). Asthma in exercising children exposed to ozone: a cohort study. Lancet 359: 386-391
23. McConnell R, Berhane K, Yao L, Jerrett M, Lurmann F, Gilliland F, Kunzli N, Gauderman J, Avol E, Thomas D and Peters J (2006). Traffic, susceptibility, and childhood asthma. Environ Health Persp 114: 766-772
24. Molitor J, Jerrett M, Chang CC, Molitor NT, Gauderman J, Berhane K, McConnell R, Kuenzli N, Lurmann F, Wu J, Winer A and Thomas D (2007). Assessing uncertainty in spatial exposure models for air pollution health effects assessment. Environ Health Persp 115: 1147-1153
25. Nijhout HF, Reed MC, Budu P and Ulrich CM (2004). A mathematical model of the folate cycle: new insights into folate homeostasis. J Biol Chem 279: 55008-55016
26. Nychka D and Saltzman N (1998). Design of air-quality monitoring networks. In: Nychka, D, Piegorsch, W and Cox, LH (eds) Case studies in environmental statistics, Lecture Notes in Statistics number 132, pp 51-75. Springer Verlag, New York
27. Pepe MS and Flemming TR (1991). A nonparametric method for dealing with mismeasured covariate data. J Am Stat Assoc 86: 108-113
28. Prentice R and Pyke R (1979). Logistic disease incidence models and case-control studies. Biometrika 86: 403-411
29. Prentice RL and Zhao LP (1991). Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses. Biometrics 47: 825-839
30. Reed MC, Nijhout HF, Sparks R and Ulrich CM (2004). A mathematical model of the methionine cycle. J Theor Biol 226: 33-43
31. Rosner B, Spiegelman D and Willett WC (1992). Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 136: 1400-1413
32. Rothman KJ and Greenland S (1998). Modern epidemiology. Lippencott-Raven, Philadelphia
33. Rubin D (1987). Multiple imputation for nonresponse in surveys. Wiley, New York
34. Thomas DC (2005). The need for a comprehensive approach to complex pathways in molecular epidemiology. Cancer Epidemiol Biomark Prev 14: 557-559
35. Thomas DC, Conti DV (2006) Two stage genetic association studies. In: Encycolpedia of clinical trials(in press)
36. Thomas DC, Stram D and Dwyer J (1993). Exposure measurement error: influence on exposure-disease relationships and methods of correction. Annu Rev Publ Health 14: 69-93
37. Ulrich CM, Robien K and Sparks R (2002). Pharmacogenetics and folate metabolism - a promising direction. Pharmacogenomics 3: 299-313
38. White JE (1982). A two stage design for the study of the relationship between a rare exposure and a rare disease. Am J Epidemiol 115: 119-128